Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tamura, T.; Ito, J.; Uriu, K.; Zahradnik, J.; Kida, I.; Nasser, H.; Shofa, M.; Oda, Y.; Lytras, S.; Nao, N.; Itakura, Y.; Deguchi, S.; Suzuki, R.; Wang, L.; Begum, M. M.; Tsuda, M.; Kosugi, Y.; Fujita, S.; Yoshimatsu, K.; Suzuki, S.; Asakura, H.; Nagashima, M.; Sadamasu, K.; Yoshimura, K.; Yamamoto, Y.; Nagamoto, T.; Schreiber, G.; The Genotype to Phenotype Japan (G2P-Japan) Consortium, ; Ikeda, T.; Fukuhara, T.; Saito, A.; Tanaka, S.; Matsuno, K.; Takayama, K.; Sato, K.
Show abstract
In late 2022, the SARS-CoV-2 Omicron subvariants have highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged by recombination of two co-circulating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022 around India. In vitro experiments revealed that XBB is the most profoundly resistant variant to BA.2/5 breakthrough infection sera ever and is more fusogenic than BA.2.75. Notably, the recombination breakpoint is located in the receptor-binding domain of spike, and each region of recombined spike conferred immune evasion and augmented fusogenicity to the XBB spike. Finally, the intrinsic pathogenicity of XBB in hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provided evidence suggesting that XBB is the first documented SARS-CoV-2 variant increasing its fitness through recombination rather than single mutations.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines 97%
- Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies 97%
- The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity 97%
Similar papers in this journal
Similar papers in this journal
- Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 96%
- Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants 94%
- A complex structure of arrestin-2 bound to a G protein-coupled receptor 93%
Similar papers in this journal
- Influenza virus ribonucleoprotein complex formation occurs in the nucleolus 96%
- Evolutionary and phenotypic characterization of spike mutations in a new SARS-CoV-2 Lineage reveals two Variants of Interest 95%
- Interferon-Inducible Guanylate-Binding Protein 5 Inhibits Replication of Multiple Viruses by Binding to the Oligosaccharyltransferase Complex and Inhibiting Glycoprotein Maturation 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.